Italian Migraine Registry (I-GRAINE-NEW)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

I-GRAINE-NEW is a multicenter observational cohort that combines retrospective chart review with prospective follow-up to map the natural history and care pathways of migraine patients entering specialized centers. The project will collect demographic, clinical, treatment history, and healthcare utilization data at baseline and during follow-up visits. Inclusion targets adults diagnosed with episodic or chronic migraine, including those with medication overuse, who provide informed consent. No experimental treatments are given as part of the registry; data are used to describe real-world disease evolution and management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult Patients(Age ≥ 18 years) of both sexes
* Diagnosis confirmed of episodic migraine ( \<15 days/month ) with or without aura or chronic migraine (\>15days/month) ,with or without headeche due to overuse of analgesics;
* Provision of signed and dated the Informed Consent Form before the inclusion in the study

Exclusion Criteria:

* Patients affected by other forms of primary or secondary headaches or in whom the diagnosis is not certain

Where it's running

• Head, Irccs San Raffaele Roma S.r.l. - Unità per la cura e la ricerca su cefalee e dolore - Dipartimento di Neurologia, Via di Val di Cannuta 250, 00166 Roma (RM) - Italy
  Roma, Roma, Italy Recruiting

Study contacts

• Study coordinator: Piero Barbanti, MD
• Email: piero.barbanti@sanraffaele.it
• Phone: +390652254027

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry

  This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.

  Recruiting Association of Migraine Disorders · North Kingstown, Rhode Island · NCT07754266

• MMA Embolization for Migraine: Patient-Reported Outcomes from a Single Site

  This registry tests whether adults with migraine who have or plan to have middle meningeal artery embolization notice changes in headaches and quality of life over time.

  Recruiting Cortex Neurovascular · Tacoma, Washington · NCT07652034

• Greater Occipital Nerve Block for Migraine with Medication Overuse Headache

  This study will test whether a nerve block using lidocaine and methylprednisolone can help people with migraine who overuse medications to reduce withdrawal headaches during detoxification.

  Recruiting at 2 sites Mahidol University · Bangkok, Bangkok and 2 other locations · NCT07568496

• Closing a PFO to improve glymphatic function and migraine symptoms

  This study will see if closing a patent foramen ovale (PFO) improves glymphatic system function and reduces migraine attacks in adults with PFO and migraine.

  Recruiting at 2 sites First Affiliated Hospital Xi'an Jiaotong University · Luoyang, Henan and 1 other locations · NCT07170176

• Topical cannabidiol (Canvert-M) for migraine attacks

  This will test whether applying Canvert-M, a topical roll-on with cannabidiol and essential oils, can reduce pain during migraine attacks in adults aged 18–55.

  Recruiting Phase 4 Alasht Pharmed · Tehran · NCT07093138

• Using closed-loop rTMS to prevent migraines

  This study is testing if a new type of brain stimulation can help people who get frequent migraines feel better and have fewer headaches.

  Recruiting Brightmind.AI · Vienna, State of Vienna · NCT06735768

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.